Table 1.
Comparison of the Demographics and Baseline Characteristics of Treatment Groups.
| Variable | Less than 3 Hours (n=156) |
3–4.5 Hours(n=36) | P-value |
|---|---|---|---|
| Age | 68 (IQR 55, 82) | 68 (IQR 54, 79) | 0.633 |
| Gender (Male) | 54% (84) | 50% (18) | 0.677 |
| Race | 0.207 | ||
| White | 57% (89) | 72% (26) | |
| Black | 41% (64) | 14% (10) | |
| Asian/Pacific Islander | 2% (3) | 0% (0) | |
| Ethnicity | |||
| Non-Hispanic | 100% (156) | 100% (36) | N/A |
| Past Medical History | |||
| Diabetes | 28% (43) | 14% (5) | 0.133 |
| HTN | 77% (120) | 67% (24) | 0.200 |
| HLD | 32% (50) | 28% (10) | 0.618 |
| Afib | 18% (28) | 31% (11) | 0.090 |
| CHF | 15% (23) | 6% (2) | 0.176 |
| CKD | 6% (10) | 0% (0) | 0.213 |
| Medications | |||
| Oral Hypoglycemics | 16% (25) | 11% (4) | 0.608 |
| Antihypertensives | 64% (100) | 50% (18) | 0.117 |
| Antiplatelet Agent | 41% (64) | 22% (8) | 0.036 |
| Current Smoker | 28% (44) | 33% (12) | 0.542 |
| Admission NIHSS | 8 (IQR 5, 15) | 8 (IQR 5,13) | 0.737 |
IQR=Interquartile Range; HTN=Hypertension; HLD=Hyperlipidemia; Afib=Atrial Fibrillation; CHF=Congestive Heart Failure; CKD=Chronic Kidney Disease; NIHSS=National Institutes of Health Stroke Scale